Boston Scientific (BSX) Long-Term Investments (2019 - 2026)
Boston Scientific's (BSX) quarterly Long-Term Investments came in at $2.2 billion in Q2 2026, up 229.66% quarter-over-quarter from $681.0 million in Q4 2025.
Powered by 
Analysis
Boston Scientific (BSX) Long-Term Investments (2019 - 2026) Analysis & Trends
Boston Scientific has disclosed Long-Term Investments across 4 years of filings, most recently posting $2.2 billion for Q2 2026.
- In Q2 2026, Long-Term Investments changed N/A year-over-year to $2.2 billion; the TTM figure through Jun 2026 stood at $2.2 billion (changed N/A YoY), while the FY2025 annual figure was $681.0 million, changed N/A from the prior year.
- Long-Term Investments came in at $2.2 billion for Q2 2026 at Boston Scientific, up from $681.0 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $2.2 billion in Q2 2026 to a low of $681.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 3.41 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | - |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 2.25 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 244.10 Mn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.25 Bn |
| Dec 31, 2025 | 681.00 Mn |
| Sep 30, 2020 | 567.00 Mn |
| Jun 30, 2020 | 467.00 Mn |
| Mar 31, 2020 | 437.00 Mn |
| Dec 31, 2019 | 458.00 Mn |